The store will not work correctly when cookies are disabled.
1-(tert-butylamino)-3-(4-(methylsulfonylmethyl)phenoxy)propan-2-ol hydrochloride
ID: ALA3247802
PubChem CID: 12363909
Max Phase: Preclinical
Molecular Formula: C15H26ClNO4S
Molecular Weight: 315.44
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)(C)NCC(O)COc1ccc(CS(C)(=O)=O)cc1.Cl
Standard InChI: InChI=1S/C15H25NO4S.ClH/c1-15(2,3)16-9-13(17)10-20-14-7-5-12(6-8-14)11-21(4,18)19;/h5-8,13,16-17H,9-11H2,1-4H3;1H
Standard InChI Key: QILYDFQEZWNMPV-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 21 0 0 0 0 0 0 0 0999 V2000
22.1604 -8.3798 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
15.7524 -10.8498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7513 -11.6771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4661 -12.0900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1825 -11.6766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1797 -10.8462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4642 -10.4370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8925 -10.4309 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.6086 -10.8407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3214 -10.4256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0375 -10.8354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3184 -9.6006 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.7503 -10.4201 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.4664 -10.8300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1792 -10.4148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4695 -11.6550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1787 -11.2415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0366 -12.0890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3224 -11.6760 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
13.6076 -12.0879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7330 -11.0873 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.5331 -10.8748 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 2 1 0
6 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
10 12 1 0
11 13 1 0
13 14 1 0
14 15 1 0
14 16 1 0
14 17 1 0
3 18 1 0
18 19 1 0
19 20 1 0
19 21 2 0
19 22 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 315.44 | Molecular Weight (Monoisotopic): 315.1504 | AlogP: 1.36 | #Rotatable Bonds: 7 |
Polar Surface Area: 75.63 | Molecular Species: BASE | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.76 | CX LogP: 0.48 | CX LogD: -1.83 |
Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.79 | Np Likeness Score: -0.97 |
References
1. Kaiser C, Jen T, Garvey E, Bowen WD, Colella DF, Wardel JR.. (1977) Adrenergic agents. 4. Substituted phenoxypropanolamine derivatives as potential beta-adrenergic agonists., 20 (5): [PMID:16136] [10.1021/jm00215a014] |